.jpeg)
What are the side effects and medication precautions of enzalutamide?
Enzalutamide, also known as enzalutamide, is a new androgen receptor inhibitor that is widely used to treat patients with advanced prostate cancer such as metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer (nmCRPC). As one of the important endocrine therapy drugs in clinical practice, enzalutamide has achieved remarkable results in improving patients' progression-free survival and overall survival. However, while the drug is effective, it is also accompanied by a series of side effects and precautions, and patients need to pay close attention during use.
1. Common side effects of enzalutamide
Enzalutamide has relatively many side effects and has certain individual differences. According to clinical research and real-world medication feedback, common adverse reactions mainly include the following categories:
1. Fatigue and weakness: One of the most common adverse reactions of enzalutamide is fatigue. According to statistics, about one-third of patients will experience varying degrees of physical fatigue or decreased energy. This feeling of fatigue may be related to the drug's inhibition of the androgen pathway, which is usually more obvious at the beginning of treatment, and some patients can gradually adapt as the medication time is extended.
2. Hot flashes and mood swings: Some patients may experience symptoms such as hot flashes and increased sweating similar to those of female menopause. At the same time, some patients reported that their mood fluctuated greatly and they experienced mild anxiety, depression or sleep disorders while taking the medicine. Although these symptoms are not serious adverse reactions, they may affect the patient's quality of life.
3. Hypertension and cardiovascular risks: Enzalutamide can cause an increase in blood pressure, especially during long-term use. Patients with pre-existing hypertension or heart disease should undergo a detailed evaluation before use and have their blood pressure monitored regularly while taking the medication. If there is a significant increase, antihypertensive drugs should be adjusted under the guidance of a doctor or suspension of treatment should be considered.
4. Risk of seizures: Enzalutamide has the ability to cross the blood-brain barrier and therefore may affect the central nervous system. In a very small number of patients (less than 1%), seizures may occur. In particular, patients with a history of epilepsy, stroke, or concurrent use of drugs that affect the nervous system need to carefully assess the risks of medication.
During the use of enzalutamide, in order to ensure efficacy and reduce the incidence of adverse reactions, the following key matters need to be paid attention to:
1. Medication time and dosage: The conventional dose of enzalutamide is once a day. It is usually recommended to take it orally at the same time every day, either on an empty stomach or after a meal. Patients should strictly follow the doctor's prescription and should not increase or decrease the dosage or stop medication at will. Sudden discontinuation of treatment may result in rapid disease progression.
2. Avoid drug interactions: Enzalutamide is an inducer of CYP3A4 and may affect the metabolism of other drugs in the body. For example, it may reduce the effectiveness of certain antiepileptic drugs, antihypertensive drugs, and anticoagulants. Therefore, patients taking enzalutamide should inform their doctors of all medications they are currently taking, including proprietary Chinese medicines and supplements, to assess potential interactions.
3. Renal and liver function assessment and adjustment: Although enzalutamide is mainly metabolized by the liver, it still needs to be used with caution in patients with renal insufficiency or liver damage. Patients with moderate to severe hepatic dysfunction may require dose adjustments or alternative treatments.
4. Elderly patients need to be closely monitored when taking medication: Since elderly patients have more underlying diseases and reduced metabolic capacity, the probability of side effects when using enzalutamide is relatively high. For patients over 70 years old, special attention should be paid to symptoms such as falls, fractures, and confusion, and auxiliary care should be added if necessary.
5. Regular re-examination during treatment: It is recommended that patients undergo re-examination every 1-3 months during the medication period, including monitoring of PSA levels, liver and kidney function, blood pressure, bone density and other indicators, so as to timely assess the treatment response and the occurrence of adverse reactions, and adjust the treatment plan in a timely manner.
3. Special groups and life suggestions
During the treatment process, in addition to paying attention to drug side effects, the patient's daily life management is also very important:
Driving and operating machinery: Since some patients may experience central reactions such as dizziness and inability to concentrate, it is recommended to avoid driving or operating dangerous machinery while taking the drug, especially in the early stages of treatment or during the dosage adjustment stage.
Diet and nutritional management: Although enzalutamide is not affected by diet, in order to reduce fatigue and enhance physical strength, it is recommended that patients maintain a balanced nutrition and appropriately supplement protein, vitamins and minerals. At the same time, controlling high-fat and high-salt diets can help control blood pressure and liver function.
Regular daily routine and psychological support: Patients should try to maintain a regular daily routine and avoid staying up late and being overworked. In addition, in the face of possible emotional problems, such as anxiety, depression, etc., it is recommended to seek professional psychological counseling or participate in a cancer support group to obtain emotional support.
Enzalutamide plays an important role in delaying the progression of prostate cancer and improving patient survival, but its adverse effects cannot be ignored. During the period of taking the medicine, patients should pay close attention to changes in their symptoms and proactively communicate with their doctors about any discomfort. If serious adverse events such as dizziness, epilepsy, severe hypertension, liver function damage, etc. occur, you should seek medical treatment immediately. For patients taking long-term medication, establishing a complete medication file, regular review plan and multidisciplinary follow-up mechanism will help improve treatment safety and quality of life.
In short, the rational use of enzalutamide, combined with professional follow-up management, will help prostate cancer patients control their disease stably in the long term and achieve the treatment goal of surviving with the disease.
Reference: https://www.drugs.com/
1. Common side effects of enzalutamide
Enzalutamide has relatively many side effects and has certain individual differences. According to clinical research and real-world medication feedback, common adverse reactions mainly include the following categories:
1. Fatigue and weakness: One of the most common adverse reactions of enzalutamide is fatigue. According to statistics, about one-third of patients will experience varying degrees of physical fatigue or decreased energy. This feeling of fatigue may be related to the drug's inhibition of the androgen pathway, which is usually more obvious at the beginning of treatment, and some patients can gradually adapt as the medication time is extended.
2. Hot flashes and mood swings: Some patients may experience symptoms such as hot flashes and increased sweating similar to those of female menopause. At the same time, some patients reported that their mood fluctuated greatly and they experienced mild anxiety, depression or sleep disorders while taking the medicine. Although these symptoms are not serious adverse reactions, they may affect the patient's quality of life.
3. Hypertension and cardiovascular risks: Enzalutamide can cause an increase in blood pressure, especially during long-term use. Patients with pre-existing hypertension or heart disease should undergo a detailed evaluation before use and have their blood pressure monitored regularly while taking the medication. If there is a significant increase, antihypertensive drugs should be adjusted under the guidance of a doctor or suspension of treatment should be considered.
4. Risk of seizures: Enzalutamide has the ability to cross the blood-brain barrier and therefore may affect the central nervous system. In a very small number of patients (less than 1%), seizures may occur. In particular, patients with a history of epilepsy, stroke, or concurrent use of drugs that affect the nervous system need to carefully assess the risks of medication.
5. Effects on liver function: Some patients may experience abnormal liver function such as increased transaminases after taking enzalutamide. It is recommended that patients regularly detect liver function indicators at the beginning of medication and during treatment. If any obvious abnormality occurs, timely intervention is required.
During the use of enzalutamide, in order to ensure efficacy and reduce the incidence of adverse reactions, the following key matters need to be paid attention to:
1. Medication time and dosage: The conventional dose of enzalutamide is once a day. It is usually recommended to take it orally at the same time every day, either on an empty stomach or after a meal. Patients should strictly follow the doctor's prescription and should not increase or decrease the dosage or stop medication at will. Sudden discontinuation of treatment may result in rapid disease progression.
2. Avoid drug interactions: Enzalutamide is an inducer of CYP3A4 and may affect the metabolism of other drugs in the body. For example, it may reduce the effectiveness of certain antiepileptic drugs, antihypertensive drugs, and anticoagulants. Therefore, patients taking enzalutamide should inform their doctors of all medications they are currently taking, including proprietary Chinese medicines and supplements, to assess potential interactions.
3. Renal and liver function assessment and adjustment: Although enzalutamide is mainly metabolized by the liver, it still needs to be used with caution in patients with renal insufficiency or liver damage. Patients with moderate to severe hepatic dysfunction may require dose adjustments or alternative treatments.
4. Elderly patients need to be closely monitored when taking medication: Since elderly patients have more underlying diseases and reduced metabolic capacity, the probability of side effects when using enzalutamide is relatively high. For patients over 70 years old, special attention should be paid to symptoms such as falls, fractures, and confusion, and auxiliary care should be added if necessary.
5. Regular re-examination during treatment: It is recommended that patients undergo re-examination every 1-3 months during the medication period, including monitoring of PSA levels, liver and kidney function, blood pressure, bone density and other indicators, so as to timely assess the treatment response and the occurrence of adverse reactions, and adjust the treatment plan in a timely manner.
3. Special groups and life suggestions
During the treatment process, in addition to paying attention to drug side effects, the patient's daily life management is also very important:
Driving and operating machinery: Since some patients may experience central reactions such as dizziness and inability to concentrate, it is recommended to avoid driving or operating dangerous machinery while taking the drug, especially in the early stages of treatment or during the dosage adjustment stage.
Diet and nutritional management: Although enzalutamide is not affected by diet, in order to reduce fatigue and enhance physical strength, it is recommended that patients maintain a balanced nutrition and appropriately supplement protein, vitamins and minerals. At the same time, controlling high-fat and high-salt diets can help control blood pressure and liver function.
Regular daily routine and psychological support: Patients should try to maintain a regular daily routine and avoid staying up late and being overworked. In addition, in the face of possible emotional problems, such as anxiety, depression, etc., it is recommended to seek professional psychological counseling or participate in a cancer support group to obtain emotional support.
Enzalutamide plays an important role in delaying the progression of prostate cancer and improving patient survival, but its adverse effects cannot be ignored. During the period of taking the medicine, patients should pay close attention to changes in their symptoms and proactively communicate with their doctors about any discomfort. If serious adverse events such as dizziness, epilepsy, severe hypertension, liver function damage, etc. occur, you should seek medical treatment immediately. For patients taking long-term medication, establishing a complete medication file, regular review plan and multidisciplinary follow-up mechanism will help improve treatment safety and quality of life.
In short, the rational use of enzalutamide, combined with professional follow-up management, will help prostate cancer patients control their disease stably in the long term and achieve the treatment goal of surviving with the disease.
Reference: https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
